Lumos Pharma Inc (LUMO)
2.30
+0.05
(+2.22%)
USD |
NASDAQ |
Jun 03, 16:00
2.35
+0.05
(+2.17%)
Pre-Market: 20:00
Lumos Pharma Price to Book Value: 1.070 for June 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 03, 2024 | 1.070 |
| May 31, 2024 | 1.047 |
| May 30, 2024 | 1.066 |
| May 29, 2024 | 1.075 |
| May 28, 2024 | 1.075 |
| May 24, 2024 | 1.141 |
| May 23, 2024 | 1.164 |
| May 22, 2024 | 1.196 |
| May 21, 2024 | 1.173 |
| May 20, 2024 | 1.219 |
| May 17, 2024 | 1.182 |
| May 16, 2024 | 1.224 |
| May 15, 2024 | 1.042 |
| May 14, 2024 | 1.187 |
| May 13, 2024 | 1.338 |
| May 10, 2024 | 1.350 |
| May 09, 2024 | 1.406 |
| May 08, 2024 | 1.396 |
| May 07, 2024 | 1.406 |
| May 06, 2024 | 1.396 |
| May 03, 2024 | 1.378 |
| May 02, 2024 | 1.415 |
| May 01, 2024 | 1.406 |
| April 30, 2024 | 1.308 |
| April 29, 2024 | 1.317 |
| Date | Value |
|---|---|
| April 26, 2024 | 1.289 |
| April 25, 2024 | 1.285 |
| April 24, 2024 | 1.301 |
| April 23, 2024 | 1.303 |
| April 22, 2024 | 1.247 |
| April 19, 2024 | 1.205 |
| April 18, 2024 | 1.219 |
| April 17, 2024 | 1.173 |
| April 16, 2024 | 1.173 |
| April 15, 2024 | 1.140 |
| April 12, 2024 | 1.229 |
| April 11, 2024 | 1.261 |
| April 10, 2024 | 1.252 |
| April 09, 2024 | 1.252 |
| April 08, 2024 | 1.233 |
| April 05, 2024 | 1.274 |
| April 04, 2024 | 1.292 |
| April 03, 2024 | 1.283 |
| April 02, 2024 | 1.320 |
| April 01, 2024 | 1.320 |
| March 31, 2024 | |
| March 28, 2024 | 0.8373 |
| March 27, 2024 | 0.8373 |
| March 26, 2024 | 0.8551 |
| March 25, 2024 | 0.8284 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3773
Minimum
Dec 12 2022
2.544
Maximum
Dec 31 2020
0.8234
Average
0.8187
Median
Oct 13 2021
Price to Book Value Benchmarks
| icad Inc | 1.341 |
| Perspective Therapeutics Inc | 3.710 |
| Palatin Technologies Inc | 19.21 |
| Bio-Path Holdings Inc | -- |
| PDS Biotechnology Corp | 2.861 |
Price to Book Value Related Metrics
| PS Ratio | 8.403 |
| PEG Ratio | -0.0216 |
| Price | 2.30 |
| Earnings Yield | -238.3% |
| Market Cap | 18.67M |
| PEGY Ratio | -0.0216 |